Biopharma Insights - page 16

VRG50635, a Drug Discovered Through Verge Genomics' AI-powered planform, Shows Promising Phase 1 Results for ALS Treatment

Verge Genomics, a frontrunner in the implementation of AI in drug discovery, recently concluded the Phase 1 clinical trial of VRG50635, an investigational drug for Amyotrophic Lateral Sclerosis (ALS). The …

Continue ›››

How to Discover a Preclinical Drug Candidate in Two Years

IgGenix Advances Therapeutic Approach to Peanut Allergies with IgG4 Monoclonal Antibodies

IgGenix, Inc., a California-based preclinical antibody discovery and development company, recently reported advances towards a potential therapeutic solution for peanut allergies based on IgG4 monoclonal antibodies.

Continue ›››

Collaborative Open-Source Approaches Are the New Norm in Life Sciences Research, According to Survey

Life sciences research has experienced significant shifts in its operational paradigms in recent years, driven largely by the advent and integration of open-source software and public cloud services. New research …

Continue ›››

The Rising Role of AI-enabled Digital Pathology in Drug Discovery

The field of pathology has experienced a major shift over the past few decades. This evolution began as early as the 1960s with the pioneering efforts in telepathology. However, the …

Continue ›››

Harnessing AI for Drug Discovery Certara Amplifies CODEX Platform Capabilities

Certara, a leader in biosimulation, has recently expanded the horizons of AI in drug discovery with the introduction of artificial intelligence (AI) capabilities and data fabric connectivity to its clinical …

Continue ›››

Collaboration Between Iktos and Curreio Harnesses AI and Cryo-EM for Drug Discovery

Iktos, a French AI-focused company specializing in new drug design, and Curreio, a Japanese cryo-electron microscopy (cryo-EM) expert, have recently entered into a collaboration agreement. The partnership aims to leverage …

Continue ›››

CEPI and aVaxziPen Partner to Advance Needle-Free Vaccine Delivery Aiming for Equitable Global Access

Needle-free vaccine delivery has emerged as a promising solution to overcome the challenges associated with frozen storage requirements, thereby improving access to vaccines. In this context, the Coalition for Epidemic …

Continue ›››

BenevolentAI Pioneers AI-Driven Drug Discovery for ALS Treatment

Incorporating AI in drug discovery is rapidly becoming a common practice in the pharmaceutical industry. The recent undertakings of UK-based biotech company BenevolentAI, which is listed on Euronext Amsterdam (BAI), …

Continue ›››

Owkin Advances AI in Drug Discovery with Launching $50 Million MOSAIC Project

Owkin, an AI biotech firm, is partnering with NanoString Technologies and other notable cancer research institutions to spearhead the MOSAIC project. MOSAIC seeks to improve our understanding of tumor structure …

Continue ›››

ReproCell, IBM, and HNCDI Debut Pharmacology-AI to Boost Efficiency of Drug Discovery

ReproCell, a well-established life sciences company, recently revealed its latest service offering, Pharmacology-AI. This service is the result of a completed EXCELERATE project, coordinated by the Hartree National Centre for …

Continue ›››

Seqera Labs Joins Forces with Genomics England to Boost Genomic Medicine Research

Seqera Labs, recognized for its secure workflow orchestration software in the life sciences domain, is aligning forces with Genomics England, a government-owned entity, which initiated the notable 100,000 Genomes Project …

Continue ›››